IMHO, knowing all of those indivuals 1st hand, they will all leave if the buyout is completed.
They feel that they have accomplished a life's work already and certainly don't need to work anymore,a nd sure as hell won't work for big pharma
Art will retire Hellman will become a CEO Ebersman will become a CEO Yang and Scheller will become functional heads at smaller biotech because they love the research